Q&A With Maureen Mealy, RN, from Johns Hopkins: Diagnosing and Treating Neuromyelitis Optica Possible with Proper Tools

Video

While it is a rare condition and no medications have been approved for its treatment patients with neuromyelitis optica can get the help they need if doctors know what they are looking for.

While it is a rare condition and no medications have been approved for its treatment patients with neuromyelitis optica can get the help they need if doctors know what they are looking for.

Maureen A. Mealy, RN, BSN, MSCN, CNRN, from Johns Hopkins University discussed how treatment and diagnosis can be handled at the 2015 Annual Meeting of the Consortium of Multiple Sclerosis Centers. Mealy said a blood test can result in "completely shifting treatment," away from multiple sclerosis and towards the proper treatment courses for patients. She also noted there are three studies underway working to find a treatment for the condition.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.